The Journal of Antibiotics · 2004 · 66 citations · 15 references
Life SciencesBiologyMicrobiologyDrug DiscoveryMicrobial BiotechnologyMycologyAntifungal AgentsFungal BiochemistryFungal BiotechnologyFungal Natural Product BiosynthesisFungal PhysiologyFungal Secondary MetabolitesAntifungal AntibioticsFungal AntibioticsFungal Bioactive CompoundsFungal Drug DiscoveryNatural Antifungal CompoundsNew Antifungal AgentsNovel Antifungal Drug Development
Three new beauvericins, designated beauvericins D, E and F, were isolated along with known beauvericin and beauvericin A, from the culture of Beauveria sp. FKI-1366 by solvent extraction, ODS column chromatography and HPLC. These compounds potentiate miconazole activity against not only wild Candida albicans but also fluconazole resistant C. albicans. Beauvericins D and E decreased the IC50 value of miconazole against fluconazole resistant C. albicans from 1.3 microM to 0.25 and 0.31 microM, respectively.
15